LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 194 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $11,000 | +12.8% | 70 | 0.0% | 0.00% | – |
Q3 2021 | $9,752 | +6.2% | 70 | 0.0% | 0.00% | – |
Q2 2021 | $9,183 | -14.0% | 70 | 0.0% | 0.00% | -100.0% |
Q1 2021 | $10,672 | -41.4% | 70 | -61.7% | 0.00% | 0.0% |
Q4 2020 | $18,199 | +4.3% | 183 | 0.0% | 0.00% | 0.0% |
Q3 2020 | $17,444 | -14.8% | 183 | 0.0% | 0.00% | -50.0% |
Q2 2020 | $20,469 | -21.4% | 183 | -48.9% | 0.00% | -33.3% |
Q1 2020 | $26,034 | -30.3% | 358 | 0.0% | 0.00% | 0.0% |
Q4 2019 | $37,336 | +4.8% | 358 | 0.0% | 0.00% | -25.0% |
Q3 2019 | $35,635 | +70.6% | 358 | +95.6% | 0.00% | +100.0% |
Q2 2019 | $20,889 | -9.2% | 183 | 0.0% | 0.00% | -33.3% |
Q1 2019 | $23,005 | -7.4% | 183 | 0.0% | 0.00% | 0.0% |
Q4 2018 | $24,833 | -50.6% | 183 | 0.0% | 0.00% | -50.0% |
Q3 2018 | $50,232 | +32.5% | 183 | 0.0% | 0.01% | +50.0% |
Q2 2018 | $37,912 | +24.8% | 183 | -0.5% | 0.00% | 0.0% |
Q1 2018 | $30,389 | +20.6% | 184 | 0.0% | 0.00% | +33.3% |
Q4 2017 | $25,195 | +0.6% | 184 | 0.0% | 0.00% | 0.0% |
Q3 2017 | $25,052 | – | 184 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BVF INC/IL | 2,626,160 | $138,136,000 | 24.17% |
KNOTT DAVID M | 1,292,566 | $67,988,972,000 | 13.87% |
GROW Partners, LLC | 200,000 | $10,520,000 | 6.41% |
Opaleye Management Inc. | 90,000 | $4,860,000,000 | 3.82% |
OBERWEIS ASSET MANAGEMENT INC/ | 213,317 | $11,220,000 | 2.72% |
First Light Asset Management, LLC | 60,242 | $3,169,000 | 2.69% |
Timpani Capital Management LLC | 98,956 | $5,205,000 | 2.59% |
Iguana Healthcare Management, LLC | 75,000 | $3,945,000 | 2.25% |
Eventide Asset Management | 134,400 | $7,069,000 | 2.18% |
ASHFORD CAPITAL MANAGEMENT INC | 215,223 | $11,321,000 | 2.16% |